Resource Center: Research report, Special populations

A 585 page report by the National Center on Addiction and Substance Abuse document the evidence defining and describing the disease of addiction/risky substance use. It describes the need for and effectiveness of wide screening and interventions treatment and disease management tools and therapies as well as the populations in greatest need of therapies. The barriers to treatment, training and education gaps, and consequences and costs of inadequate prevention and treatment are all described. Finally, profound gaps between those who need treatment and those who receive quality care are described.

This study examined the efficacy of methadone in relieving cancer pain and also discusses side effects.

This report by NIDA discusses the HIV/AIDS epidemic and how treating drug abuse is effective in preventing HIV.

Short article summarizing the results of a recent study looking at extending the role of buprenorphine for treatment of adolescents.

This report describes points of intersection between HIV and primary care treatment, and discusses how to integrate HIV care into primary medicine.

This publication discusses the medical co-management of hepatitis infection and opioid abuse.

This website provides online access to findings from three national studies of drug abuse treatment effectiveness funded by the National Institute on Drug Abuse. The information is usefully organized by population (adults and adolescents) and modality (outpatient methadone, outpatient drug-free, short-term inpatient, and long-term residential).

A study on the treatment of Chronic Pain Syndrome with Buprenorphine.